These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [Helicobacter pylori: a new pathogen to be considered in infancy]. Herrera Montes I; Villa Carbo JJ; Miranda Casas C; Caballero Morales T; Castejón Casado FJ; Sánchez Lopez-Tello C An Esp Pediatr; 1991 May; 34(5):373-5. PubMed ID: 1883112 [TBL] [Abstract][Full Text] [Related]
48. Effect of Helicobacter pylori eradication on antral gastrin- and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Queiroz DM; Mendes EN; Rocha GA; Moura SB; Resende LM; Barbosa AJ; Coelho LG; Passos MC; Castro LP; Oliveira CA Scand J Gastroenterol; 1993 Oct; 28(10):858-64. PubMed ID: 7903471 [TBL] [Abstract][Full Text] [Related]
49. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence]. Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208 [TBL] [Abstract][Full Text] [Related]
50. G- and D-cell populations, serum and tissue concentrations of gastrin and somatostatin in patients with peptic ulcer diseases. Park SM; Park HS Korean J Intern Med; 1993 Jan; 8(1):1-7. PubMed ID: 7903552 [TBL] [Abstract][Full Text] [Related]
51. Helicobacter pylori infection and gastroduodenal disease: a comparison of endoscopic findings, histology, and urease test data. Haruma K; Okamoto S; Sumii K; Yoshihara M; Tari A; Teshima H; Shimamoto T; Takehara Y; Tanaka S; Yamamoto G Hiroshima J Med Sci; 1992 Sep; 41(3):65-70. PubMed ID: 1293070 [TBL] [Abstract][Full Text] [Related]
52. Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis. Liu Y; Vosmaer GD; Tytgat GN; Xiao SD; Ten Kate FJ J Clin Pathol; 2005 Sep; 58(9):927-31. PubMed ID: 16126872 [TBL] [Abstract][Full Text] [Related]
53. Impairment of gastric secretion modulation in duodenal ulcer and in long-term PPI treatment: quantitative morphologic findings and pathophysiologic implications. Bechi P; Bacci S; Cianchi F; Amorosi A; Nesi G; Dei R; Romagnoli P Dig Dis Sci; 2001 Sep; 46(9):1952-9. PubMed ID: 11575448 [TBL] [Abstract][Full Text] [Related]
54. [Prevalence of polyresistance to antibiotics among Helicobacter pylori strains isolated from patients with gastroduodenal zone diseases]. Khetsuriani ShG; Rachvelishvili BKh; Khetsuriani KG Ter Arkh; 2006; 78(2):19-21. PubMed ID: 16613090 [TBL] [Abstract][Full Text] [Related]
56. Helicobacter pylori and the pathogenesis of gastroduodenal disease: Implications for the management of peptic ulcer disease. Rotimt O; Nduduba DA; Otegbeye FM Niger Postgrad Med J; 2005 Dec; 12(4):289-98. PubMed ID: 16380742 [TBL] [Abstract][Full Text] [Related]
57. Rationale for eradication of Helicobacter pylori infection in duodenal ulcer disease. Malfertheiner P; Domínguez-Muñoz JE Clin Ther; 1993; 15 Suppl B():37-48. PubMed ID: 8205594 [TBL] [Abstract][Full Text] [Related]